Mark Oette
Researcher Next ID · RN-032126
Researcher · Biochemistry, Genetics and Molecular Biology
Krankenhaus der Augustinerinnen
Cologne, Germany
- Works count
- 1,574
- Citation count
- 2,507
- H-index
- 27
- i10-index
- 67
Research interests
Publications
Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients
Infection · 2021 · 10.1007/s15010-020-01573-7
Failure of Dolutegravir First-Line ART with Selection of Virus Carrying R263K and G118R
New England Journal of Medicine · 2019 · 10.1056/nejmc1806554
Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study
Haematologica · 2018 · 10.3324/haematol.2017.180893
Proviral DNA as a Target for HIV-1 Resistance Analysis
Intervirology · 2015 · 10.1159/000431093
German‐Austrian guidelines on anal dysplasia and anal cancer in HIV‐positive individuals: prevention, diagnosis, and treatment
JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2015 · 10.1111/ddg.12726
Survival of AIDS ‐related diffuse large B‐cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort
British Journal of Haematology · 2014 · 10.1111/bjh.13221
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
Infection · 2013 · 10.1007/s15010-013-0504-1
Pneumocystis Pneumonia
Journal · 2009 · 10.1007/978-3-540-29676-8_3214
Portal Vein Thrombosis
Journal · 2009 · 10.1007/978-3-540-29676-8_1442
Hereditary Angioedema
Journal · 2009 · 10.1007/978-3-540-29676-8_9206
Photosensitive Epilepsy
Journal · 2009 · 10.1007/978-3-540-29676-8_6574
Primary Hyperoxalurias
Journal · 2009 · 10.1007/978-3-540-29676-8_9319
Purine Nucleoside Phosphorylase Deficiency
Journal · 2009 · 10.1007/978-3-540-29676-8_1508
Pyruvate Carboxylase Deficiency
Journal · 2009 · 10.1007/978-3-540-29676-8_1518
Proliferative Diabetic Retinopathy
Journal · 2009 · 10.1007/978-3-540-29676-8_8323
Pulmonary Sarcoidosis
Journal · 2009 · 10.1007/978-3-540-29676-8_6775
Pseudoxanthoma Elasticum
Journal · 2009 · 10.1007/978-3-540-29676-8_1488
Pityriasis Versicolor
Journal · 2009 · 10.1007/978-3-540-29676-8_3345
Papillon-Lefèvre Syndrome
Journal · 2009 · 10.1007/978-3-540-29676-8_1366
Prevalence of minor variants of HIV strains at reverse transcriptase position 103 in therapy-naïve patients and their impact on the virological failure
Journal of Clinical Virology · 2009 · 10.1016/j.jcv.2009.03.002
Human Transmissible Spongiform Encephalopathies
Journal · 2009 · 10.1007/978-3-540-29676-8_614
Treatment of Spondylodiscitis in Human Immunodeficiency Virus-Infected Patients
Spine · 2009 · 10.1097/brs.0b013e3181a0aa5b
Heredopathia Atactica Polyneuritiformis
Journal · 2009 · 10.1007/978-3-540-29676-8_6293
Progressive Familial Intrahepatic Cholestasis
Journal · 2009 · 10.1007/978-3-540-29676-8_9324
Primary Open Angle Glaucoma
Journal · 2009 · 10.1007/978-3-540-29676-8_8593
Polycystic Disease (Kidney)
Journal · 2009 · 10.1007/978-3-540-29676-8_1428
Protein-Energy Malnutrition
Journal · 2009 · 10.1007/978-3-540-29676-8_6165
Hereditary Spherocytosis
Journal · 2009 · 10.1007/978-3-540-29676-8_9223
Hereditary Hemochromatosis
Journal · 2009 · 10.1007/978-3-540-29676-8_9213
Hashimoto's Thyroiditis
Journal · 2009 · 10.1007/978-3-540-29676-8_747
Hereditary Progressive Dystonia with Marked Diurnal Fluctuation
Journal · 2009 · 10.1007/978-3-540-29676-8_8362
Hepatic Encephalopathy
Journal · 2009 · 10.1007/978-3-540-29676-8_771
Peripheral Facial Paralysis
Journal · 2009 · 10.1007/978-3-540-29676-8_8480
Hypersensitivity Type I
Journal · 2009 · 10.1007/978-3-540-29676-8_8768
Trends of prevalence of primary HIV drug resistance in Germany
Journal of Antimicrobial Chemotherapy · 2007 · 10.1093/jac/dkm274
Compensatory Mutations at the HIV Cleavage Sites P7/P1 and P1/P6-Gag in Therapy-Naive and Therapy-Experienced Patients
Antiviral Therapy · 2006 · 10.1177/135965350601100708
Primary HIV Drug Resistance and Efficacy of First-Line Antiretroviral Therapy Guided by Resistance Testing
JAIDS Journal of Acquired Immune Deficiency Syndromes · 2006 · 10.1097/01.qai.0000214805.52723.c1
Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study
Annals of Oncology · 2006 · 10.1093/annonc/mdl063
Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy.
PubMed · 2005
Computational methods for the design of effective therapies against drug resistant HIV strains
Computer applications in the biosciences · 2005 · 10.1093/bioinformatics/bti654
Characterization of Novel HIV Drug Resistance Mutations Using Clustering, Multidimensional Scaling and SVM-Based Feature Ranking
Lecture notes in computer science · 2005 · 10.1007/11564126_30
Psychomotor Slowing in Hepatitis C and HIV Infection
JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 10.1097/00126334-200402010-00005
Long‐term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapy
HIV Medicine · 2002 · 10.1046/j.1464-2662.2001.00091.x
Lipodystrophy Syndrome and Self-Assessment of Well-Being and Physical Appearance in HIV-Positive Patients
AIDS Patient Care and STDs · 2002 · 10.1089/108729102760330254
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals
AIDS · 2000 · 10.1097/00002030-200006160-00015
Current projects
No projects listed.